Long-term, cause-specific mortality after myocardial infarction in diabetes

European Heart Journal

Volumn 25, Issue 11, 2004, Pages 926-931

  Timmer, Jorik R ^a   Ottervanger, Jan Paul ^a   Thomas, Karen ^a   Hoorntje, Jan C A ^a   De Boer, Menko Jan ^a   Suryapranata, Harry ^a   Zijlstra, Felix ^b  

^a ISALA HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Angioplasty; Clinical outcome; Diabetes; Myocardial infarction

Indexed keywords

FIBRINOLYTIC AGENT; STREPTOKINASE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REPERFUSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; ST SEGMENT ELEVATION;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; DIABETIC ANGIOPATHIES; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; STREPTOKINASE; SURVIVAL ANALYSIS;

EID: 3042788482     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ehj.2004.04.001     Document Type: Article

References (42)

1. Mak K.H., Moliterno D.J., Granger C.B., et al. Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries. J. Am. Coll. Cardiol. 30:1997;171-179
2. Waldecker B., Waas W., Haberbosch W., et al. Type 2 diabetes and acute myocardial infarction. Angiographic findings and results of an invasive therapeutic approach in type 2 diabetic versus nondiabetic patients. Diabetes Care. 22:1999;1832-1838
3. Hsu L.F., Mak K.H., Lau K.W., et al. Clinical outcomes of patients with diabetes mellitus and acute myocardial infarction treated with primary angioplasty or fibrinolysis. Heart. 88:2002;260-265
4. Hasdai D., Granger C.B., Srivatsa S.S., et al. Diabetes mellitus and outcome after primary coronary angioplasty for acute myocardial infarction: lessons from the GUSTO-IIb angioplasty substudy. Global use of strategies to open occluded arteries in acute coronary syndromes. J. Am. Coll. Cardiol. 35:2000;1502-1512
5. Gustafsson I., Hildebrandt P., Seibaek M., et al. Long-term prognosis of diabetic patients with myocardial infarction: relation to antidiabetic treatment regimen. The TRACE Study Group. Eur. Heart J. 21:2000;1937-1943
6. Behar S., Boyko V., Reicher-Reiss H., et al. Ten-year survival after acute myocardial infarction: comparison of patients with and without diabetes. SPRINT Study Group. Secondary Prevention Re-infarction Israeli Nifedipine Trial. Am. Heart J. 133:1997;290-296
7. Mukamal K.J., Nesto R.W., Cohen M.C., et al. Impact of diabetes on long-term survival after acute myocardial infarction: comparability of risk with prior myocardial infarction. Diabetes Care. 24:2001;1422-1427
8. Zijlstra F., Hoorntje J.C.A., de Boer M.J., et al. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N. Engl. J. Med. 341:1999;1413-1419
9. Zijlstra F., de Boer M.J., Hoorntje J.C.A., et al. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N. Engl. J. Med. 328:1993;680-684
10. de Boer M.J., Hoorntje J.C.A., Ottervanger J.P., et al. Immediate coronary angioplasty versus intravenous streptokinase in acute myocardial infarction: left ventricular ejection fraction, hospital mortality and reinfarction. J. Am. Coll. Cardiol. 23:1994;1004-1008
11. Madsen J.K., Grande P., Saunamaki K., et al. Danish multicenter randomized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI). DANish trial in Acute Myocardial Infarction. Circulation. 96:1997;748-755
12. Husband D.J., Alberti K.G., Julian D.G. Stress hyperglycaemia during acute myocardial infarction: an indicator of pre-existing diabetes? Lancet. 2:1983;179-181
13. Malmberg K., Ryden L., Efendic S., et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J. Am. Coll. Cardiol. 26:1995;57-65
14. de Boer M.J., Suryapranata H., Hoorntje J.C.A., et al. Limitation of infarct size and preservation of left ventricular function after primary coronary angioplasty compared with intravenous streptokinase in acute myocardial infarction. Circulation. 90:1994;753-761
15. Zijlstra F., de Boer M.J., Suryapranata H. Treatment of acute myocardial infarction. N. Engl. J. Med. 329:1993;432
16. Zijlstra F., Beukema W.P., van 't Hof A.W.J., et al. Randomized comparison of primary coronary angioplasty with thrombolytic therapy in low risk patients with acute myocardial infarction. J. Am. Coll. Cardiol. 29:1997;908-912
17. Hinkle L.E. Jr., Thaler H.T. Clinical classification of cardiac deaths. Circulation. 65:1982;457-464
18. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53:1958;457-481
19. Cox D.R. Regression models and life-tables. J. R. Statist. Soc. 34:1972;187-220
20. Jaski B.E., Cohen J.D., Trausch J., et al. Outcome of urgent percutaneous transluminal coronary angioplasty in acute myocardial infarction: comparison of single-vessel versus multivessel coronary artery disease. Am Heart J. 124:1992;1427-1433
21. Svedjeholm R., Hakanson E., Vanhanen I. Rationale for metabolic support with amino acids and glucose-insulin-potassium (GIK) in cardiac surgery. Ann. Thorac. Surg. 59:1995;S15-S22
22. Ishihara M., Inoue I., Kawagoe T., et al. Diabetes mellitus prevents ischaemic preconditioning in patients with a first acute anterior wall myocardial infarction. J. Am. Coll. Cardiol. 38:2001;1007-1011
23. Ottervanger J.P., van 't Hof A.W.J., Reiffers S., et al. Long-term recovery of left ventricular function after primary angioplasty for acute myocardial infarction. Eur. Heart J. 22:2001;785-790
24. Winocour P.D. Platelet abnormalities in diabetes mellitus. Diabetes. 41(Suppl 2):1992;26-31
25. Kreisberg R.A. Diabetic dyslipidemia. Am. J. Cardiol. 82:1998;67U-73U
26. Solang L., Malmberg K., Ryden L. Diabetes mellitus and congestive heart failure. Further knowledge needed. Eur. Heart J. 20:1999;789-795
27. Vehkavaara S., Seppala-Lindroos A., Westerbacka J., et al. In vivo endothelial dysfunction characterizes patients with impaired fasting glucose. Diabetes Care. 22:1999;2055-2060
28. Rubler S., Dlugash J., Yuceoglu Y.Z., et al. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am. J. Cardiol. 30:1972;595-602
29. Ewing D.J., Campbell I.W., Clarke B.F. Assessment of cardiovascular effects in diabetic autonomic neuropathy and prognostic implications. Ann. Int. Med. 92:1980;308-311
30. Balkau B., Jouven X., Ducimetiere P., et al. Diabetes as a risk factor for sudden death. Lancet. 354:1999;1968-1969
31. Whang W., Bigger J.T. Jr. Diabetes and outcomes of coronary artery bypass graft surgery in patients with severe left ventricular dysfunction: results from The CABG Patch Trial database. The CABG Patch Trial Investigators and Coordinators. J. Am. Coll. Cardiol. 36:2000;1166-1172
32. Lomuscio A., Vergani D., Marano L., et al. Effects of glibenclamide on ventricular fibrillation in non-insulin-dependent diabetics with acute myocardial infarction. Coron. Artery Dis. 5:1994;767-771
33. Gray R.P., Yudkin J.S., Patterson D.L. Enzymatic evidence of impaired reperfusion in diabetic patients after thrombolytic therapy for acute myocardial infarction: a role for plasminogen activator inhibitor? Br. Heart J. 70:1993;530-536
34. Fath-Ordoubadi F., Beatt K.J. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials. Circulation. 96:1997;1152-1156
35. van der Horst I.C.C., Zijlstra F., van 't Hof A.W.J., et al. Glucose-insulin-potassium infusion in patients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin-potassium study: a randomized trial. J. Am. Coll. Cardiol. 42:2003;792-795
36. Malmberg K., Norhammar A., Wedel H., et al. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation. 99:1999;2626-2632
37. Van Belle E., Perie M., Braune D., et al. Effects of coronary stenting on vessel patency and long-term clinical outcome after percutaneous coronary revascularization in diabetic patients. J. Am. Coll. Cardiol. 40:2002;410-417
38. Sousa J.E., Costa M.A., Sousa A.G., et al. Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries. Circulation. 107:2003;381-383
39. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N. Engl. J. Med. 346:2002;877-883
40. Shekelle P.G., Rich M.W., Morton S.C., et al. Efficacy of angiotensin-converting enzyme inhibitors and β-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials. J. Am. Coll. Cardiol. 41:2003;1529-1538
41. Gaede P., Vedel P., Larsen N., et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N. Engl. J. Med. 348:2003;383-393
42. Neumann F.J., Blasini R., Schmitt C., et al. Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction. Circulation. 98:1998;2695-2701